Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).

HHS Secretary Robert F. Kennedy Jr. appears to be planning major changes to the way his department oversees vaccines, media ...

The postponed ACIP meeting comes barely a week after Robert F. Kennedy, Jr. was confirmed as Secretary of Health and Human ...

Originally scheduled for next week, the meeting of agency advisers will be delayed to give more time for public comment, an HHS spokesperson said.

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Key CDC vaccine committee meeting pushed ...

A Centers for Disease Control and Prevention vaccine advisory committee meeting scheduled for next week — the first since ...

A meeting of U.S. vaccine advisers set for late February has been postponed, a federal official confirmed on Thursday, ...

A panel of experts advising the U.S. Centers for Disease Control and Prevention on vaccines will not convene for its February ...

The CDC's Advisory Committee on Immunization Practices was set to meet beginning February 26 and provide recommendations ...

The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active ...

“To reduce the risk of infection, individuals should avoid close contact with infected individuals, practise good hand hygiene, and consider vaccination for meningococcal disease, which is alway ...

Kennedy's nomination has been controversial because of his long-expressed views on a variety of health topics, including skepticism over vaccines. The former Democratic candidate for president ...